THE ROLE OF ZDHHC7 AND S-PALMITOYLATION IN ANTIVIRAL INNATE IMMUNITY
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
Protein lipidation including cysteine palmitoylation (S-palmitoylation) significantly enhances protein hydrophobicity and membrane association. S-palmitoylation, catalyzed by the ZDHHC (zinc finger Asp-His-His-Cys) family of enzymes, occurs on a broad range of substrates. This modification regulates numerous biological pathways and cellular events, demonstrating significant relevance to various diseases. S-palmitoylation has been demonstrated to be critical for immune and inflammatory responses. However, understanding of the involvement of S-palmitoylation in antiviral immunity against RNA viruses remains very limited. RIG-I-like receptors (RLR) mediate innate immune signaling by detecting viral RNA and initiating the production of antiviral genes. In this study, we identified the S-palmitoylation of MAVS, a C-terminal tail-anchored protein on the mitochondrial outer membrane that functions downstream of RLR in antiviral signaling. We characterized ZDHHC7 as its palmitoyltransferase, modifying Cys508, a residue near the tail-anchor transmembrane helix. The transmembrane domain of tail-anchored proteins is usually sufficient for their sorting and maintaining correct localization. We are curious about the function of S-palmitoylation for tail-anchored proteins. Mechanistically, MAVS S-palmitoylation does not affect its localization at resting state. However, in response to viral challenges, MAVS S-palmitoylation stabilizes and promotes the aggregation of tail-anchored MAVS on the mitochondrial outer membrane, which provides important insights into how lipidation could affect tail-anchored or integral membrane proteins. Accordingly, ZDHHC7-mediated MAVS palmitoylation enhances antiviral response, and deletion of ZDHHC7 in mice increases susceptibility of the host to RNA virus infections, demonstrating a pro-inflammatory effect of ZDHHC7. The role of protein S-palmitoylation and how ZDHHCs are regulated under specific biological contexts needs to be further investigated. Furthermore, we found that treatment with the pan palmitoyl transferase inhibitor, 2-bromopalmitate, suppressed the development of systemic lupus erythematosus in a mouse model, suggesting that perturbation of lipid metabolism and protein lipidation could potentially benefit the treatment of autoimmune diseases. However, the underlying mechanisms of this effect require further exploration.